临床试验和动物研究中的样本量计算

Alireza Pakgohar, H. Mehrannia
{"title":"临床试验和动物研究中的样本量计算","authors":"Alireza Pakgohar, H. Mehrannia","doi":"10.18502/ijdo.v16i1.15241","DOIUrl":null,"url":null,"abstract":"\n \n \nObjective: This review aims to address the critical role of sample size calculation in designing and conducting animal studies related to diabetes and obesity, particularly focusing on experimental comparison methods like ANOV A design. \nMaterials and Methods: We discuss the factors influencing sample size decisions, including type I and type II errors, effect size, and standard deviation. We emphasize the importance of avoiding common pitfalls, such as using rules of thumb or arbitrary choices, and advocate for utilizing established formulas to ensure accurate and reliable sample size determination. \nResults: This review presents relevant equations for calculating sample size in animal studies with an ANOV A design, providing researchers with a framework for determining the appropriate number of animals needed to achieve robust and ethical research. \nConclusion: Accurate sample size calculation is essential for achieving powerful and statistically sound animal studies in diabetes and obesity research. Utilizing established formulas and avoiding arbitrary choices ensures reliable and ethical research practices while minimizing resource waste and maximizing the validity of collected data. \n \n \n","PeriodicalId":33205,"journal":{"name":"Iranian Journal of Diabetes and Obesity","volume":"3 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sample Size Calculation in Clinical Trial and Animal Studies\",\"authors\":\"Alireza Pakgohar, H. Mehrannia\",\"doi\":\"10.18502/ijdo.v16i1.15241\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n \\n \\nObjective: This review aims to address the critical role of sample size calculation in designing and conducting animal studies related to diabetes and obesity, particularly focusing on experimental comparison methods like ANOV A design. \\nMaterials and Methods: We discuss the factors influencing sample size decisions, including type I and type II errors, effect size, and standard deviation. We emphasize the importance of avoiding common pitfalls, such as using rules of thumb or arbitrary choices, and advocate for utilizing established formulas to ensure accurate and reliable sample size determination. \\nResults: This review presents relevant equations for calculating sample size in animal studies with an ANOV A design, providing researchers with a framework for determining the appropriate number of animals needed to achieve robust and ethical research. \\nConclusion: Accurate sample size calculation is essential for achieving powerful and statistically sound animal studies in diabetes and obesity research. Utilizing established formulas and avoiding arbitrary choices ensures reliable and ethical research practices while minimizing resource waste and maximizing the validity of collected data. \\n \\n \\n\",\"PeriodicalId\":33205,\"journal\":{\"name\":\"Iranian Journal of Diabetes and Obesity\",\"volume\":\"3 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iranian Journal of Diabetes and Obesity\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18502/ijdo.v16i1.15241\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Diabetes and Obesity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ijdo.v16i1.15241","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:本综述旨在探讨样本量计算在设计和开展与糖尿病和肥胖症有关的动物研究中的关键作用,尤其侧重于方差分析等实验比较方法。材料与方法:我们讨论了影响样本量决策的因素,包括 I 型和 II 型误差、效应大小和标准偏差。我们强调了避免使用经验法则或任意选择等常见误区的重要性,并提倡使用既定公式来确保样本量确定的准确性和可靠性。结果:本综述介绍了在采用方差分析设计的动物研究中计算样本量的相关公式,为研究人员提供了一个框架,用于确定实现稳健和道德研究所需的适当动物数量。结论在糖尿病和肥胖症研究中,准确计算样本量对于开展有说服力且统计合理的动物研究至关重要。利用既定公式,避免随意选择,可确保研究实践可靠、符合伦理,同时最大限度地减少资源浪费,并最大限度地提高所收集数据的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Sample Size Calculation in Clinical Trial and Animal Studies
Objective: This review aims to address the critical role of sample size calculation in designing and conducting animal studies related to diabetes and obesity, particularly focusing on experimental comparison methods like ANOV A design. Materials and Methods: We discuss the factors influencing sample size decisions, including type I and type II errors, effect size, and standard deviation. We emphasize the importance of avoiding common pitfalls, such as using rules of thumb or arbitrary choices, and advocate for utilizing established formulas to ensure accurate and reliable sample size determination. Results: This review presents relevant equations for calculating sample size in animal studies with an ANOV A design, providing researchers with a framework for determining the appropriate number of animals needed to achieve robust and ethical research. Conclusion: Accurate sample size calculation is essential for achieving powerful and statistically sound animal studies in diabetes and obesity research. Utilizing established formulas and avoiding arbitrary choices ensures reliable and ethical research practices while minimizing resource waste and maximizing the validity of collected data.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
25
审稿时长
26 weeks
期刊最新文献
Vildagliptin-Associated Bullous Pemphigoid: A Case Report A Comparison of Renal Effects between Empagliflozin and Linagliptin in Diabetic Patients with Chronic Kidney Disease: A Randomized Clinical Trial Genetic and Epigenetic Etiologies of Type 1 Diabetes Mellitus Predictors of Mortality among Intensive Care Unit (ICU) Hospitalized Diabetic Patients with COVID-19 Antibody Engineering to Enhancement of Ranibizumab Binding Affinity for the Prevention and Treatment of Diabetic Retinopathy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1